Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Investigated for use/treatment in colorectal cancer and inflammatory bowel disease.
- Mechanism
- Curator reviewed
Declopramide is a member of the N-substituted benzamide class of DNA repair inhibitors. There are two possible mechanisms of action of declopramide, with one involving (nuclear localizing factor kappaB) NFkB and the other involving the activation of the caspase cascade via the mitochondrial pathway, both of which lead to cell death (apoptosis). Declopramide may also increase the susceptibility of cancer cells to traditional radiation and/or chemotherapy treatment. It is proposed that G2/M cell cycle block is induced by pathways other than the protein 53 (p53) pathway.
- Primary indication
- Investigated for use/treatment in colorectal cancer and inflammatory bowel disease.Curator reviewed
- Formula / weight
- C13H20ClN3O · 269.77 g/mol (avg)
Resolves to
YEYAKZXEBSVURO-UHFFFAOYSA-NSMILESCCN(CC)CCNC(=O)C1=CC=C(N)C(Cl)=C1What you can answer from here — as of March 06, 2025
Which drugs share a target with Declopramide, and which of those have an active Phase 3 trial?